Xencor, Inc.
XNCRNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $1.82B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $10.38$30.61
- Volume (live)
- -
- Avg. volume (3M)
- 1.42M
Xencor (XNCR) Stock Price & Financial Analysis
Xencor Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $22.76 - $24.21 |
|---|---|
| 52-Week High | $30.61 |
| 52-Week Low | $10.38 |
| Open | $24.02 |
| Volume (last close) | 1.13M |
| Average Volume (3M) | 1.42M |
| Revenue (TTM) | 104.97M |
|---|---|
| Net Income (TTM) | -163.32M |
| Free Cash Flow (TTM) | -208.28M |
| EPS (TTM) | −$2.18 |
| Profit Margin | -155.59% |
| Operating Margin | -205.84% |
| Return on Equity (ROE) | -32.46% |
| Debt to Equity | 0.21 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.82B |
|---|---|
| Shares Outstanding | 75.86M |
| Price to Sales (P/S) | 17.34 |
| Price to Book (P/B) | 3.62 |
| EV/EBITDA | -15.22 |
| 50-Day MA | $24.89 |
|---|---|
| 200-Day MA | $16.23 |
| 1-Year Change | +62.49% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Xencor at a Glance
As of the Oct 16, 2026 close, Xencor (XNCR) has a market capitalization of $1.82B. The stock trades at 17.3× sales. Over the trailing twelve months it lost $163.32M on revenue of $104.97M and burned $208.28M of free cash flow. Revenue fell 36.0% year over year.
As of its latest reported balance sheet, it holds $44.66M in cash and securities against $104.89M of debt, a net debt position of $60.23M.
Xencor does not currently pay a dividend.
The share price is up 62.5% over the past year. At $22.85 (the Oct 16, 2026 close) it sits within its 52-week range of $10.38 to $30.61, above its 200-day moving average of $16.23.
Based on 14 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $31.83, 39.3% above the Oct 16, 2026 close.
Frequently Asked Questions About Xencor
What is the current stock price for XNCR?
As of the Oct 16, 2026 close, XNCR stock trades at $22.85. The 52-week range is $10.38–$30.61, with a day range of $22.76–$24.21.
What is the P/E ratio for XNCR?
The P/E ratio (Price-to-Earnings) for XNCR is shown in the Key Statistics section. This valuation metric helps compare Xencor, Inc. to industry peers.
Does XNCR pay dividends?
Xencor does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for XNCR?
Based on ratings from 14 professional analysts over the last 90 days, the consensus for XNCR is Buy. The average 12-month price target is $31.83, a 39.3% upside from the Oct 16, 2026 close of $22.85.
What is the market cap of XNCR?
As of the Oct 16, 2026 close, Xencor's market capitalization is $1.73B, classifying it as a small-cap company. Xencor operates in the Healthcare sector within the Biotechnology industry.